Immunotherapy combo shows promise in delaying bladder cancer progression
Disease control
Completed
This study tested whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) could help delay cancer growth in people with advanced bladder cancer that had not worsened after initial chemotherapy. The trial included 25 adults with unresectable or metastatic uroth…
Phase: PHASE2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated May 17, 2026 04:11 UTC